Another review speculates about the beneficial use of anti-IL-17A and anti-IL-23 antibody in AD by interfering with neutrophil infiltration and thereby suggets another possible effector cell in IL-23-mediated neuroinflammation in AD (71). The gene discussed is IL17A; the disease is Alzheimer disease.